Pinsent Masons advises Yule Catto on the sale of Uquifa

01 Dec 2011 | 10:49 am | 1 min. read

International law firm Pinsent Masons has advised Yule Catto & Co plc, international producer of speciality chemicals, on the sale of its pharmaceuticals business, Uquifa to the listed Indian chemicals manufacturer Vivimed Labs for £35m.

Uquifa, which operates through Spanish and Mexican subsidiaries, is an established manufacturer of active pharmaceutical ingredients. The company has manufacturing sites in Spain and Mexico employing a total of 390 people. 

Adrian Whitfield, Chief Executive of Yule Catto said: "I am delighted to be able to announce this disposal.  Following the PolymerLatex acquisition we completed earlier this year, this marks the final step in a long process of transforming Yule Catto into a substantial highly focussed Specialty Polymer business.  We are pleased we have been able to find a good home for our Pharma business and wish the new owners and our former employees every success." 

The Pinsent Masons team advising on the sale was led by Martin Shaw, Head of Corporate, Europe, and Shiv Sibal, Senior Associate, supported by Emma Metcalfe (corporate), Michael Hunter and Jon Robinson (tax).  The team also worked closely with Yule Catto's Spanish advisers, Garrigues, and their Mexican advisers, Baker & McKenzie. Vivimed were advised by Dickinson Dees. 

Shiv Sibal, Corporate Senior Associate at Pinsent Masons LLP, commented: "The sale of Uquifa represents an important development for Yule Catto and will allow them to continue to focus on the growth of their Polymers division following their transformational acquisition of PolymerLatex earlier this year.  Having worked closely with them on the PolymerLatex acquisition, we are delighted to have supported Yule Catto again in achieving one of its strategic objectives."

Latest press releases

Show me all press releases

Pinsent Masons advises PIC on £132m buy-in of Tomkins 2008 pension scheme retirement benefits plan

Pinsent Masons advises PIC on £132m buy-in of Tomkins 2008 pension scheme retirement benefits plan.

Pinsent Masons advises on Umicore’s € 591 million sustainability linked note fundraising

Multinational law firm Pinsent Masons has advised various institutional investors in relation to Umicore’s € 591 million sustainability linked note fundraising.

Pinsent Masons advises Alveo on its sale to Symphony Technology Group

Pinsent Masons has advised the shareholders of Alveo, including funds managed by Sovereign Capital Partners (SCP), on its sale to Symphony Technology Group (STG).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Statkraft on landmark partnership with Copenhagen Infrastructure Partners 

Multinational law firm Pinsent Masons has advised Statkraft on the sale of a 50% stake in their Irish offshore wind portfolio to Copenhagen Infrastructure Partners’ fund, Copenhagen Infrastructure IV K/S, as part of its plans to develop up to 2.2 gigawatts of offshore wind in Ireland.

Pinsent Masons advises Saint-Gobain Limited on the £740m sale of its UK distribution business

Multinational law firm Pinsent Masons is advising Saint-Gobain Limitedon the sale of all its UK distribution business to the Stark Group. 

Pinsent Masons advises Halma plc on the acquisition of WEETECH Holding GmbH

Multinational law firm Pinsent Masons has advised Halma plc on the acquisition of WEETECH Holding GmbH - the holding company of WEETECH GmbH and its subsidiaries based in Wertheim, Germany.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.